Comparative Study of Shatapushpa Tail Uttarbasti & Sharpunkha Ghan Vati in the management of Vandhyatva (Anovulation)
试验速览
- 阶段
- 2/3 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 30
- 试验地点
- 1
- 主要终点
- Improvement in Dominant follicle size & Endometrial thickness.
研究概览
简要总结
In randomised comparative clinical trial on 30 diagnosed vandhyatva (female Infertility) w.s.r. Anovulatory factor. Female Patients of child Bearing age (18-40yrs) having active married life minimum 1 year
and suffering from Infertility with at least 2 or more consecutive anovulatory cycles were included. Female Patients having age less than 18years and more than 40years and Congenital deformities , infectious
diseases of reproductive tract like tuberculosis, Sexually transmitted diseases and carcinoma, DM, HIV, HTN were excluded. Group A patients were given with Sharpunkha Ghan Vati in a dose of 500 mg tds for 7 days for 2 month. Group B patients were given with Shatapushpa Tail Uttaarbasti 5 ml for 2 consecutive cycles.
Conclusion: In Nut cell, it can be concluded that Shatapushpa tail Uttarbasti is more effective compared to Sharpunkha Ghan Vati. Final conclusion of the study will be arrived at only after completion of the study.
研究设计
- 研究类型
- Interventional
- 分配方式
- Computer generated randomization
- 盲法
- Open Label
入排标准
- 年龄范围
- 18.00 Year(s) 至 40.00 Year(s)（—）
- 性别
- Female
入选标准
- •Patient having complaint of failure to conceive (due to Anovulation) within one or more year of regular unprotected coitus.
- •Age groups-18 to 40 years 3.Primary or secondary infertility with Anovulatory factors.
排除标准
- •1.Infertility due to other factor like uterine factor, cervical factor, tubal factor, peritoneal factor.
- •2.Infertility due to abnormality in male partner.
- •3.Patient suffering from chronic diseases like Hypertension, Diabetes mellitus, Malignancy, Thyroid disorder, Severe anaemia, Tuberculosis etc.
- •4.Patient suffering from Hepatitis B, sexually transmitted diseases, human immunodeficiency virus (HIV).
- •5.Congenital anatomical defect of female genital organ 6.Surgical factors like Ovarian tumour, Ovarian endometrioma, etc.
- •7.Contraindication of Uttar Basti (like Genital tract infection, heavy bleeding, etc.).
结局指标
主要结局
Improvement in Dominant follicle size & Endometrial thickness.
时间窗: Improvement in Dominant follicle size & Endometrial thickness.
次要结局
- Improvement in Interval of menstrual cycle, Duration of Bleeding, Dyspareunia(60 days)